Breast and Ovarian Cancer [NEW TOPIC PAGE]

Main|Search|PHGKB




Last Posted: Jun 25, 2020

---

• Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
  De Simone Lenika M et al. Journal of genetic counseling 2020 Jun
• Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer.
  Simoes Correa-Galendi Julia et al. Applied health economics and health policy 2020 Jun
• Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
  Li Dan et al. Breast cancer (Tokyo, Japan) 2020 Jun
• Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.
  Isselhard A et al. Trials 2020 Jun 21(1) 501
• "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
  Gill Gulvir et al. Psycho-oncology 2020 Jun
• Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
  Armel Susan Randall et al. Gynecologic oncology 2020 Jun
• Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
  Cragun Deborah et al. Breast cancer research and treatment 2020 May
• Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
  Hurry Manjusha et al. International journal of technology assessment in health care 2020 Apr 36(2) 104-112
• Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome.
  Santonocito Concetta et al. Cancers 2020 May 12(5)
• Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents.
  Savatt Juliann M et al. BMC pediatrics 2020 May 20(1) 222

more